Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly

PHASE1CompletedINTERVENTIONAL

Enrollment

113

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

DiabetesHealthy

Interventions

DRUG

semaglutide

Administered subcutaneously (s.c., under the skin)once daily or once weekly.

DRUG

placebo

Administered subcutaneously (s.c., under the skin)once daily or once weekly.

Trial Locations (1)

Novo Nordisk Investigational Site, Berlin